
Henry Schein (HSIC) Stock Forecast & Price Target
Henry Schein (HSIC) Analyst Ratings
Bulls say
Henry Schein is a trusted and established company in the healthcare industry, with a global presence and strong customer satisfaction focus. Its leadership in the dental market and strategy for sustainable earnings growth make it a positive investment option, although it does face competition and potential risks such as cyber attacks. The company's recent financial results have been better than expected and the announcement of a new CEO with M&A experience could lead to further growth opportunities. Opinions are mixed on the potential impact of healthcare laws on the company, but its strong brand and potential for growth make it a favorable stock in the healthcare sector. Other companies in the industry have varying ratings and price targets.
Bears say
Henry Schein is facing risks related to their growth and competition in the industry, along with potential risks associated with their expansion into software services and potential changes in healthcare legislation. However, the company has a clear M&A strategy focused on high-growth and high-margin businesses, with a strong focus on margins and growth. The new Chief Strategic Officer, with a background in M&A, is expected to play a significant role in driving the company's global strategic planning, and HSIC expects at least 50% of their future operating income to come from these high-growth segments.
This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.
Henry Schein (HSIC) Analyst Forecast & Price Prediction
Start investing in Henry Schein (HSIC)
Order type
Buy in
Order amount
Est. shares
0 shares